Ocrevus vs. Mavenclad

Reviewed on 11/25/2019

Are Ocrevus and Mavenclad the Same Thing?

Ocrevus (ocrelizumab) injection and Mavenclad (cladribine) are used to treat relapsing forms of multiple sclerosis (MS).

Ocrevus is also used to treat primary progressive forms of multiple sclerosis (MS).

Because of its safety profile, use of Mavenclad is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS.

Ocrevus and Mavenclad belong to different drug classes. Ocrevus is a CD20-directed cytolytic antibody and Mavenclad is a purine antimetabolite.

Side effects of Ocrevus and Mavenclad that are similar include upper respiratory tract infection and back pain.

Side effects of Ocrevus that are different from Mavenclad include lower respiratory tract infections, infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate), skin infections, depression, and pain in the extremities.

Side effects of Mavenclad that are different from Ocrevus include headache, low white blood cell count (lymphopenia), nausea, joint pain, and insomnia.

Both Ocrevus and Mavenclad may interact with other immune-modulating or immunosuppressive therapies, including immunosuppressant doses of corticosteroids.

Mavenclad may also interact with hematotoxic drugs, antiviral and antiretroviral drugs, ritonavir, eltrombopag, curcumin, cyclosporine, dilazep, nifedipine, nimodipine, cilostazol, sulindac, dipyridamole, reserpine, interferon-beta, rifampicin, St. John's wort, and hormonal contraceptives.

What Are Possible Side Effects of Ocrevus?

Common side effects of Ocrevus include:

  • upper respiratory tract infections,
  • infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate),
  • skin infections,
  • lower respiratory tract infections,
  • depression,
  • back pain, and
  • pain in the extremities.

What Are Possible Side Effects of Mavenclad?

Common side effects of Mavenclad include:

  • upper respiratory tract infection,
  • headache,
  • low white blood cell count (lymphopenia),
  • nausea,
  • back pain,
  • joint pain, and
  • insomnia

What Is Ocrevus?

Ocrevus (ocrelizumab) injection is aCD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.

What Is Mavenclad?

Mavenclad (cladribine) is a purine antimetabolite indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, use of Mavenclad is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS.

SLIDESHOW

What Is Multiple Sclerosis? MS Symptoms, Causes, Diagnosis See Slideshow

What Drugs Interact With Ocrevus?

Ocrevus may interact with other immune-modulating or immunosuppressive therapies, including immunosuppressant doses of corticosteroids. Tell your doctor all medications and supplements you use.

What Drugs Interact With Mavenclad?

Mavenclad may interact with immunosuppressive drugs, hematotoxic drugs, antiviral and antiretroviral drugs, ritonavir, eltrombopag, curcumin, cyclosporine, dilazep, nifedipine, nimodipine, cilostazol, sulindac, dipyridamole, reserpine, interferon-beta, corticosteroids, rifampicin, St. John's wort, or hormonal contraceptives. Tell your doctor all medications and supplements you use. Mavenclad is not recommended for use during pregnancy; it may harm a fetus. Pregnancy should be excluded before the initiation of each treatment course of Mavenclad. Females of reproductive potential should prevent pregnancy by use of effective contraception during Mavenclad dosing and for at least 6 months after the last dose in each treatment course. Males of reproductive potential should take precautions to prevent pregnancy of their partner during Mavenclad dosing and for at least 6 months after the last dose in each treatment course. Because of the potential for serious adverse reactions in nursing infants, Mavenclad is not recommended for use while breastfeeding.

How Should Ocrevus Be Taken?

Hepatitis B virus screening is required before the first dose of Ocrevus. Pre-medicate with methylprednisolone (or an equivalent corticosteroid) and an antihistamine prior to each infusion. The starting dose of Ocrevus is 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion. Subsequent doses of Ocrevus are 600 mg intravenous infusion every 6 months.

How Should Mavenclad Be Taken?

The cumulative dosage of 3.5 mg/kg Mavenclad is administered orally and divided into 2 treatment courses (1.75 mg/ kg per treatment course). Each treatment course is divided into 2 treatment cycles.

QUESTION

What kind of disease is multiple sclerosis? See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Genentech. Ocrevus Product Monograph.

https://www.ocrevus.com

Serono. Mavenclad Product Information

www.mavenclad.com/?

Health Solutions From Our Sponsors